10.1074/jbc.M109.030130 J
Additionally, the clinical presentation of G6PD-deficient patients may vary, so a well-designed large-scale clinical study or an animal model scalable to the human immune system would be required in order to provide sufficient evidence of this point
That research has not yet progressed to randomized, controlled human clinical trials for any indication a distinction that applies across the entire BPC-157 product category, not just to ProHealth's formulation
Request third-party HPLC chromatograms showing purity greater than 98%, mass spectrometry reports confirming correct molecular weight (1419.55 Da for BPC-157, for example), and certificates of analysis including endotoxin testing results
Vlachakis D, Mitsis T, Nicolaides N, et al